Holding(s) in Company

Summary by AI BETAClose X

The Goldman Sachs Group Inc. has notified Oxford Biomedica PLC of a change in its major holdings, crossing a threshold on September 16, 2026. The firm now holds a total of 5.083440% of voting rights, comprising 0.001408% directly attached to shares and 5.082032% through various financial instruments including securities lending and cash-settled swaps. This notification reflects an acquisition or disposal of voting rights and financial instruments, with the total number of voting rights held amounting to 6,153,493.

Disclaimer*

Oxford Biomedica PLC
21 September 2026
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDFBVT43

Issuer Name

OXFORD BIOMEDICA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

The Goldman Sachs Group Inc

City of registered office (if applicable)

Wilmington, Delaware

Country of registered office (if applicable)

USA

4. Details of the shareholder

Name

City of registered office

Country of registered office

Goldman Sachs International

London

United Kingdom

5. Date on which the threshold was crossed or reached

16-Sep-2026

6. Date on which Issuer notified

18-Sep-2026

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.001408

5.082032

5.083440

6153493

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BDFBVT43

 

1704

 

0.001408

Sub Total 8.A

1704

0.001408%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Securities Lending

Open

 

3985217

3.292213

Sub Total 8.B1

 

3985217

3.292213%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Swap

07-August-2036

 

Cash

816815

0.674776

Swap

12-March-2036

 

Cash

350029

0.289161

Swap

14-July-2036

 

Cash

285237

0.235636

Swap

02-September-2036

 

Cash

255772

0.211295

Swap

15-January-2030

 

Cash

191146

0.157907

Swap

18-August-2036

 

Cash

60467

0.049952

Swap

10-June-2031

 

Cash

53374

0.044093

Swap

05-December-2030

 

Cash

44172

0.036491

Swap

22-July-2036

 

Cash

34534

0.028529

Swap

07-September-2029

 

Cash

23545

0.019451

Swap

13-August-2029

 

Cash

14489

0.011969

Swap

15-September-2036

 

Cash

11481

0.009484

Swap

20-August-2027

 

Cash

6313

0.005215

Swap

03-September-2029

 

Cash

5599

0.004625

Swap

30-April-2027

 

Cash

4296

0.003549

Swap

06-September-2027

 

Cash

4255

0.003515

Swap

26-August-2036

 

Cash

2918

0.002411

Swap

01-September-2036

 

Cash

1501

0.001240

Swap

16-September-2031

 

Cash

393

0.000325

Swap

23-August-2027

 

Cash

171

0.000141

Swap

03-September-2036

 

Cash

65

0.000054

Sub Total 8.B2

 

2166572

1.789819%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Goldman Sachs Group, Inc. (Chain 1)

 

 

 

 

The Goldman Sachs Group, Inc. (Chain 1)

Goldman Sachs & Co. LLC

 

 

 

The Goldman Sachs Group, Inc. (Chain 2)

 

 

 

 

The Goldman Sachs Group, Inc. (Chain 2)

GSAM Holdings LLC

 

 

 

The Goldman Sachs Group, Inc. (Chain 2)

Goldman Sachs Asset Management, L.P.

 

 

 

The Goldman Sachs Group, Inc. (Chain 3)

 

 

 

 

The Goldman Sachs Group, Inc. (Chain 3)

Goldman Sachs (UK) L.L.C.

 

5.082032

5.082032%

The Goldman Sachs Group, Inc. (Chain 3)

Goldman Sachs Group UK Limited

 

5.082032

5.082032%

The Goldman Sachs Group, Inc. (Chain 3)

Goldman Sachs International

 

5.082032

5.082032%

The Goldman Sachs Group, Inc. (Chain 4)

 

 

 

 

The Goldman Sachs Group, Inc. (Chain 4)

Goldman Sachs Bank USA

 

 

 

The Goldman Sachs Group, Inc. (Chain 4)

Goldman Sachs Bank Europe SE

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

If date does not apply, explain below

 

11. Additional Information

Please note, the total amount of voting rights have been rounded to 6 decimal places therefore there is a possibility of a rounding error.

General email contact:
gs-regops-emea-position-enquiries@gs.com

12. Date of Completion

18-Sep-2026

13. Place Of Completion

Bengaluru

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100